CLOs on the Move

Utah Cancer Foundation

www.utahcancerfoundation.org

 
Utah Cancer Foundation is a Salt Lake City, UT-based company in the Non-profit sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

National Breast Cancer Foundation

The National Breast Cancer Foundation is the leading community-funded organisation in Australia raising money for research into the prevention and cure of breast cancer. In total, since 1994, NBCF has awarded more than $127 million to around 430 Australian-based research projects to improve the health and well-being of those affected by breast cancer. We are very proud that the National Breast Cancer Foundation raises and grants funds exclusively for research, because we believe research is the most effective way to end breast cancer. We are also very proud of the fact that the National Breast Cancer Foundation has a commitment to funding research right across the spectrum – from understanding the fundamental basis of the disease to psychosocial research aimed at improving the quality of life for survivors. Our aspirational goal is to achieve zero deaths from breast cancer by 2030. With 42 Australians diagnosed each day and seven dying from the disease, there is still much to do.

Community Action Partnrsp Kern

Community Action Partnrsp Kern is a Bakersfield, CA-based company in the Non-profit sector.

Bill Reid Foundation

Bill Reid Foundation is a Vancouver, BC-based company in the Non-profit sector.

The Learning Enrichment Foundation

The Learning Enrichment Foundation is a York, ON-based company in the Non-profit sector.

National Brain Tumor Society

Driven by a vibrant, hopeful, and tireless community, the National Brain Tumor Society`s strategic initiatives and funded programs aim to improve an understanding of all brain tumors to transform research into new and effective treatments, as quickly as possible. To achieve these goals, we also foster collaboration with leaders in the private sector, government, and academia to drive systemic change within all facets of the drug discovery and development landscape.